Novel Brain Stimulation Therapies in Stroke Guided Expressions of Plasticity
Completed · Early Phase 1 · Has a placebo group
Conditions studied: Stroke, Cerebrovascular Disorders, Nervous System Diseases, Brain Diseases, Cardiovascular Diseases, Vascular Diseases, Central Nervous System Diseases
In brief
The investigators ultimate goal is to personalize brain stimulation for stroke so outcomes of the upper limb can be maximized for each individual patient. Several groups including the investigators have recently theorized that personalizing stimulation so as to selectively stimulate iM1 in mild, and cPMd in patients with greater severity would help generalize benefits of stimulation. The investigator premise that variances in expressions of plasticity can explain how to best stratify patients for robust, personalized stimulation.
Key facts
- Study ID
- NCT03020433
- Run by
- The Cleveland Clinic
- People needed
- 37
- Starts
- 2016-03-01
- Expected to finish
- 2019-12-01
- Last updated by the study team
- 2020-07-16
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- greater than 21 years old
- more than 6 months from first, unilateral index stroke
- unilateral paresis of the upper limb indexed as greater than or equal to 20% slowness in functional reaching compared to non-paretic limb
- UEFM less than or equal to 61 out of 66.
You may not qualify if…
- subjects who cannot perform reaching with shoulder
- severe cognitive deficit (less than or equal to 24 on Mini-Mental State examination.
- contraindication to TMS or MRI including: seizures, ongoing use of certain neuro- or psycho-active medications, implants, or pacemaker.
- currently receiving outpatient therapy.
Where it is running
- Cleveland Clinic Foundation — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.